CN Patent

CN111954531A — α聚谷氨酸化培美曲塞及其用途

Assigned to LEAF Holdings Group LLC · Expires 2020-11-17 · 5y expired

What this patent protects

本公开总体上涉及α聚谷氨酸化培美曲塞、含有填充有α聚谷氨酸化培美曲塞的脂质体的制剂、制备含有所述α聚谷氨酸化培美曲塞和脂质体的制剂的方法，以及使用含有α聚谷氨酸化培美曲塞和脂质体的制剂来治疗过度增生性病症(例如，癌症)和免疫系统病症(例如，自身免疫性疾病，如类风湿性关节炎)的方法。

USPTO Abstract

本公开总体上涉及α聚谷氨酸化培美曲塞、含有填充有α聚谷氨酸化培美曲塞的脂质体的制剂、制备含有所述α聚谷氨酸化培美曲塞和脂质体的制剂的方法，以及使用含有α聚谷氨酸化培美曲塞和脂质体的制剂来治疗过度增生性病症(例如，癌症)和免疫系统病症(例如，自身免疫性疾病，如类风湿性关节炎)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN111954531A
Jurisdiction
CN
Classification
—
Expires
2020-11-17
Drug substance claim
No
Drug product claim
No
Assignee
LEAF Holdings Group LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.